Literature DB >> 26703820

Granulomatous Dermatitis as a Cutaneous Manifestation of Hematologic Disorders: The First Case Associated With Polycythemia Vera and a New Case Associated With Myelodysplasia.

B Lozano-Masdemont1, O Baniandrés-Rodríguez2, V Parra-Blanco3, R Suárez-Fernández2.   

Abstract

Granulomatous dermatitis has been associated with hematologic disorders, including the myelodysplastic syndromes. We describe the first case of granulomatous dermatitis associated with polycythemia vera, presenting as large erythematous nodules mimicking panniculitis. We also present the seventh case associated with myelodysplasia, with erythematous plaques on the face and neck, similar to a neutrophilic dermatosis. We consider it particularly interesting for dermatologists to be aware of this dermatosis as a nonspecific manifestation of various hematologic disorders. We suggest performing additional tests (complete blood count) to exclude the possibility that the skin manifestations are the initial sign of hematologic disease. Furthermore, we propose using the broader term, granulomatous dermatitis, to refer to these disorders as, although there are more reports of interstitial forms, cases with a more nodular presentation have also been published, and the importance of the diagnosis derives not from the subtype but from the relationship with an underlying disease.
Copyright © 2015 AEDV. Published by Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Dermatitis granulomatosa; Granulomatous dermatitis; Mielodisplasia; Myelodysplasia; Myelodysplastic syndrome; Policitemia vera; Polycythemia vera; Síndrome mielodisplásico

Mesh:

Year:  2015        PMID: 26703820     DOI: 10.1016/j.ad.2015.05.017

Source DB:  PubMed          Journal:  Actas Dermosifiliogr        ISSN: 0001-7310


  1 in total

1.  Interstitial Granulomatous Dermatitis due to a Rare Myeloproliferative Neoplasia.

Authors:  Sandra Cases-Merida; Ana Lorente-Lavirgen; Amalia Pérez-Gil
Journal:  Indian J Dermatol       Date:  2018 May-Jun       Impact factor: 1.494

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.